RBM48
RNA-binding protein 48
Also known as: C7orf64, DKFZp564O0523, HSPC304, RBM48_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5RL73
- Gene
- RBM48
- Ensembl
- ENSG00000127993
- Chromosome
- 7
- Canonical length
- 367 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable RNA binding activity. Predicted to be involved in RNA splicing and mRNA processing. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
367 residues, UniProt reviewed canonical sequence.
>Q5RL73|RBM48
1 MASSGGELGS LFDHHVQRAV CDTRAKYREG RRPRAVKVYT INLESQYLLI QGVPAVGVMK
61 ELVERFALYG AIEQYNALDE YPAEDFTEVY LIKFMNLQSA RTAKRKMDEQ SFFGGLLHVC
121 YAPEFETVEE TRKKLQMRKA YVVKTTENKD HYVTKKKLVT EHKDTEDFRQ DFHSEMSGFC
181 KAALNTSAGN SNPYLPYSCE LPLCYFSSKC MCSSGGPVDR APDSSKDGRN HHKTMGHYNH
241 NDSLRKTQIN SLKNSVACPG AQKAITSSEA VDRFMPRTTQ LQERKRRRED DRKLGTFLQT
301 NPTGNEIMIG PLLPDISKVD MHDDSLNTTA NLIRHKLKEV ISSVPKPPED KPEDVHTSHP
361 LKQRRRILocalizationUniProt · AlphaFold · HPA
Whether an antibody against RBM48 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 13 nTPM
- spinal cord: 9.2 nTPM
- skeletal muscle: 9 nTPM
- cerebellum: 8.9 nTPM
- midbrain: 8.3 nTPM
- cerebral cortex: 8.2 nTPM
Single-cell type
- oligodendrocytes: 50 nCPM
- myonuclei: 35 nCPM
- oocytes: 32 nCPM
- esophageal apical cells: 32 nCPM
- b-cells: 31 nCPM
- nk-cells: 31 nCPM
Immune cell
- basophil: 68 nTPM
- naive CD4 T-cell: 32 nTPM
- eosinophil: 30 nTPM
- naive B-cell: 29 nTPM
- memory B-cell: 29 nTPM
- naive CD8 T-cell: 27 nTPM
Brain region
- white matter: 24 nTPM
- cerebral cortex: 22 nTPM
- cerebellum: 21 nTPM
- basal ganglia: 19 nTPM
- pons: 19 nTPM
- thalamus: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RBM48.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 98 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.32
- DepMap mean gene effect
- -0.66
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA-binding domain superfamily
- RBM48, RNA recognition motif
- RNA-binding protein 48
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RBM48 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RBM48 as an antibody target. Whether an autoantibody or antibody against RBM48 could matter depends on whether native RBM48 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RBM48 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RBM48 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...